A new study published in The American Journal of Pathology provides new evidence that immune cells enter the retina via the body's standard pathway, identifying Platelet Endothelial Cell Adhesion Molecule (PECAM; also known as CD31) as the gatekeeper and neutrophils as proresolving mediators. This research offers new insights into how eye inflammation develops and could lead to better-targeted treatment options.
